Skip to main content
. 2021 Dec 7;12(25):2476–2488. doi: 10.18632/oncotarget.28088
Terminology and abbreviations
Cell fusion A process of merging two or more cells into one by merging their plasma membranes.
Fusogen An agent, often a protein such as SARS-CoV-2 spike, capable of fusing cellular membranes. Viral fusogens fuse the viral
envelope to the plasma membrane of the target cell and can fuse plasma membranes of adjacent cells to each other.
Syncytium ( plural  syncytia) A multinucleated cell produced by the fusion of two or more cells. The term comes from Greek syn “together” and kytos
“box, or cell”.
Heterokaryon A syncytium produced from more than one cell type, say, a pneumocyte fused to an epithelial progenitor or a leukocyte.
Homokaryon A syncytium produced from cells of the same type, as would be the case with the fusion of two or more pneumocytes.
Cell hybrid Mononuclear offspring of syncytia, produced once a syncytium undergoes mitosis. For example, hybridomas are
made by fusing leukocytes with plasmacytoma cells to obtain hybrids that produce monoclonal antibodies.
PS (phosphatidylserine) The most abundant anionic (negatively charged) membrane lipid. In live cells, PS is actively moved to the
cytoplasmic side of plasma membrane.
Scramblases Proteins, such as TMEM16F, that randomize, or scramble, the asymmetric distribution of PS across
the membrane, a process known as  PS externalization .